These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 30445530)

  • 21. Is there long-term value of pathology scoring in immunoglobulin A nephropathy? A validation study of the Oxford Classification for IgA Nephropathy (VALIGA) update.
    Coppo R; D'Arrigo G; Tripepi G; Russo ML; Roberts ISD; Bellur S; Cattran D; Cook TH; Feehally J; Tesar V; Maixnerova D; Peruzzi L; Amore A; Lundberg S; Di Palma AM; Gesualdo L; Emma F; Rollino C; Praga M; Biancone L; Pani A; Feriozzi S; Polci R; Barratt J; Del Vecchio L; Locatelli F; Pierucci A; Caliskan Y; Perkowska-Ptasinska A; Durlik M; Moggia E; Ballarin JC; Wetzels JFM; Goumenos D; Papasotiriou M; Galesic K; Toric L; Papagianni A; Stangou M; Benozzi L; Cusinato S; Berg U; Topaloglu R; Maggio M; Ots-Rosenberg M; D'Amico M; Geddes C; Balafa O; Quaglia M; Cravero R; Lino Cirami C; Fellstrom B; Floege J; Egido J; Mallamaci F; Zoccali C;
    Nephrol Dial Transplant; 2020 Jun; 35(6):1002-1009. PubMed ID: 30418652
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A validation study of crescents in predicting ESRD in patients with IgA nephropathy.
    Zhang X; Shi S; Ouyang Y; Yang M; Shi M; Pan X; Lv J; Wang Z; Ren H; Shen P; Wang W; Zhang H; Xie J; Chen N
    J Transl Med; 2018 May; 16(1):115. PubMed ID: 29724226
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation of the Oxford Classification of IgA nephropathy: a systematic review and meta-analysis.
    Lv J; Shi S; Xu D; Zhang H; Troyanov S; Cattran DC; Wang H
    Am J Kidney Dis; 2013 Nov; 62(5):891-9. PubMed ID: 23820066
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Outcomes of immunosuppression in IgA nephropathy based on the oxford classification.
    Palamuthusingam D; Castledine C; Lawman S
    Saudi J Kidney Dis Transpl; 2018; 29(2):341-350. PubMed ID: 29657202
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Value of the Oxford classification of IgA nephropathy in children with Henoch-Schönlein purpura nephritis.
    Xu K; Zhang L; Ding J; Wang S; Su B; Xiao H; Wang F; Zhong X; Li Y
    J Nephrol; 2018 Apr; 31(2):279-286. PubMed ID: 29185209
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mesangial C4d deposition may predict progression of kidney disease in pediatric patients with IgA nephropathy.
    Fabiano RCG; de Almeida Araújo S; Bambirra EA; Oliveira EA; Simões E Silva AC; Pinheiro SVB
    Pediatr Nephrol; 2017 Jul; 32(7):1211-1220. PubMed ID: 28233100
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Microangiopathic Lesions in IgA Nephropathy: A Cohort Study.
    Cai Q; Shi S; Wang S; Ren Y; Hou W; Liu L; Lv J; Haas M; Zhang H
    Am J Kidney Dis; 2019 Nov; 74(5):629-639. PubMed ID: 31103332
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Utilizing the MEST score for prognostic staging in IgA nephropathy.
    Haaskjold YL; Bjørneklett R; Bostad L; Bostad LS; Lura NG; Knoop T
    BMC Nephrol; 2022 Jan; 23(1):26. PubMed ID: 35016634
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Oxford Classification predictors of chronic kidney disease in pediatric patients with IgA nephropathy.
    Fabiano RCG; Araújo SA; Bambirra EA; Oliveira EA; Simões E Silva AC; Pinheiro SVB
    J Pediatr (Rio J); 2017; 93(4):389-397. PubMed ID: 28130969
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Risk factors of progressive IgA nephropathy which progress to end stage renal disease within ten years: a case-control study.
    Shu D; Xu F; Su Z; Zhang J; Chen C; Zhang J; Ding X; Lv Y; Lin H; Huang P
    BMC Nephrol; 2017 Jan; 18(1):11. PubMed ID: 28061828
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Addition of eGFR and Age Improves the Prognostic Absolute Renal Risk-Model in 1,134 Norwegian Patients with IgA Nephropathy.
    Knoop T; Vågane AM; Vikse BE; Svarstad E; Magnúsdóttir BT; Leh S; Varberg Reisæter A; Bjørneklett R
    Am J Nephrol; 2015; 41(3):210-9. PubMed ID: 25872002
    [TBL] [Abstract][Full Text] [Related]  

  • 32. IgA nephropathy: prognostic classification of end-stage renal failure. L'Association des Néphrologues de l'Est.
    Frimat L; Briançon S; Hestin D; Aymard B; Renoult E; Huu TC; Kessler M
    Nephrol Dial Transplant; 1997 Dec; 12(12):2569-75. PubMed ID: 9430853
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Kidney Failure Risk Prediction Equations in IgA Nephropathy: A Multicenter Risk Assessment Study in Chinese Patients.
    Xie J; Lv J; Wang W; Li G; Liu Z; Chen H; Xu F; Sun J; Ouyang Y; Zhang X; Yang M; Shi M; Zhang W; Ren H; Kiryluk K; Zhang H; Chen N
    Am J Kidney Dis; 2018 Sep; 72(3):371-380. PubMed ID: 29555434
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Validation of the revised Oxford classification for IgA nephropathy considering treatment with corticosteroids/immunosuppressors.
    Moriyama T; Karasawa K; Miyabe Y; Akiyama K; Ogura S; Takabe T; Sugiura N; Seki M; Iwabuchi Y; Uchida K; Nitta K
    Sci Rep; 2020 Jul; 10(1):11151. PubMed ID: 32636449
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prognostic value of endocapillary hypercellularity in IgA nephropathy patients with no immunosuppression.
    Chakera A; MacEwen C; Bellur SS; Chompuk LO; Lunn D; Roberts ISD
    J Nephrol; 2016 Jun; 29(3):367-375. PubMed ID: 26318019
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical Significance of Crescent Formation in IgA Nephropathy - a Multicenter Validation Study.
    Park S; Baek CH; Park SK; Kang HG; Hyun HS; Park E; Han SH; Ryu DR; Kim DK; Oh KH; Joo KW; Kim YS; Moon KC; Chin HJ; Lee H
    Kidney Blood Press Res; 2019; 44(1):22-32. PubMed ID: 30808840
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immunoglobulin a nephropathy: Pathological markers of renal survival in paediatric patients.
    Fabiano RC; Pinheiro SV; de Almeida Araújo S; Simões E Silva AC
    Nephrology (Carlton); 2016 Dec; 21(12):995-1002. PubMed ID: 27414046
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Reversal of active glomerular lesions after immunosuppressive therapy in patients with IgA nephropathy: a repeat-biopsy based observation.
    Shen XH; Liang SS; Chen HM; Le WB; Jiang S; Zeng CH; Zhou ML; Zhang HT; Liu ZH
    J Nephrol; 2015 Aug; 28(4):441-9. PubMed ID: 25585823
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Application of Oxford classification, and overexpression of transforming growth factor-β1 and immunoglobulins in immunoglobulin A nephropathy: correlation with World Health Organization classification of immunoglobulin A nephropathy in a Chinese patient cohort.
    Meng H; Zhang L; E X; Ye F; Li H; Han C; Yamakawa M; Jin X
    Transl Res; 2014 Jan; 163(1):8-18. PubMed ID: 23891568
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Validation of Oxford Classification of Immunoglobulin A Nephropathy: an Iranian Experience.
    Sadeghipour A; Hendi A; Asgari M; Sotoudeh M; Parvin M; Filip I; Radfar A; Babaheidarian P
    Iran J Kidney Dis; 2016 Jan; 10(1):17-21. PubMed ID: 26837676
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.